James A H, Britt R P, Raskino C L, Thompson S G
Department of Haematology, Hillington Hospital, Uxbridge, Middlesex.
J Clin Pathol. 1992 Aug;45(8):704-6. doi: 10.1136/jcp.45.8.704.
To identify the possible factors determining the dose of warfarin prescribed in patients receiving anticoagulant treatment.
The computerised records of 2305 patients maintained on the drug in seven hospitals were amalgamated and classified into one of seven diagnostic groups. The associations with the dose of warfarin prescribed were investigated by univariate and multiple regression analysis. Differences between hospitals were studied with regard to the coagulometric method and the thromboplastin preparation used.
The geometric mean dose of warfarin was 4.57 mg and 5% of patients were prescribed 10 mg or greater. There was a noticeable decrease in dose with increasing age, which averaged about 6 mg for patients aged 30 but 3.5 mg for those aged 80. Men required slightly more warfarin than women. Patients with heart disease or atrial fibrillation required lower doses of warfarin, while higher doses were required by patients with deep vein thrombosis. Significant differences in mean warfarin dose among the seven hospitals were evident. These differences could not be explained entirely by the use of different coagulometric methods or thromboplastins.
Clinicians should be aware that older patients need reduced doses of warfarin. The considerable differences in doses of warfarin among hospitals indicates that further efforts to improve uniformity are required.
确定接受抗凝治疗患者华法林处方剂量的可能决定因素。
合并七家医院2305例服用该药物患者的计算机记录,并将其分为七个诊断组之一。通过单因素和多因素回归分析研究与华法林处方剂量的相关性。研究了各医院在凝血测定方法和所用凝血活酶制剂方面的差异。
华法林的几何平均剂量为4.57mg,5%的患者处方剂量为10mg或更高。随着年龄增长,剂量明显降低,30岁患者平均约为6mg,而80岁患者为3.5mg。男性所需华法林略多于女性。患有心脏病或心房颤动的患者所需华法林剂量较低,而患有深静脉血栓形成的患者则需要较高剂量。七家医院之间华法林平均剂量存在显著差异。这些差异不能完全用不同的凝血测定方法或凝血活酶来解释。
临床医生应意识到老年患者需要降低华法林剂量。医院之间华法林剂量的显著差异表明需要进一步努力提高一致性。